Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and β-catenin

Cancer Research

Volumn 73, Issue 17, 2013, Pages 5473-5484

  Saud, Shakir M ^a   Young, Matthew R ^a   Jones Hall, Yava L ^c   Ileva, Lilia ^b   Evbuomwan, Moses O ^a   Wise, Jennifer ^b   Colburn, Nancy H ^a   Kim, Young S ^a   Bobe, Gerd ^d,e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c PURDUE UNIVERSITY   (United States)

^d OREGON STATE UNIVERSITY   (United States)

^e OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; ISORHAMNETIN; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CELL NUCLEUS; COLITIS; COLORECTAL CANCER; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; THERAPY EFFECT; TUMOR VOLUME;

ANIMALS; APOPTOSIS; AZOXYMETHANE; BETA CATENIN; BLOTTING, WESTERN; CELL NUCLEUS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DEXTRAN SULFATE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICE; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN TRANSPORT; QUERCETIN; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SRC-FAMILY KINASES; TUMOR CELLS, CULTURED;

EID: 84883466738     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-0525     Document Type: Article

References (40)

1. American CS. Cancer facts & figures 2011. Atlanta, GA: American Cancer Society; 2011.
2. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology 2002;16:217-26.
3. Shenoy AK, Fisher RC, Butterworth EA, Pi L, Chang LJ, Appelman HD, et al. Transition from colitis to cancer: high Wnt activity sustains the tumor-initiating potential of colon cancer stem cell precursors. Cancer Res 2012;72:5091-100.
4. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35. (Pubitemid 32234798)
5. Gyde S, Prior P, Dew MJ, Saunders V, Waterhouse JA, Allan RN. Mortality in ulcerative colitis. Gastroenterology 1982;83:36-43. (Pubitemid 12123685)
6. Lieu C, Kopetz S. The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy. Clin Colorectal Cancer 2010;9:89-94.
7. Aligayer H, Boyd DD, Heiss MM, Abdalla EK, Curley SA, Gallick GE. Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis. Cancer 2002;94:344-51. (Pubitemid 34081362)
8. Cam WR, Masaki T, Shiratori Y, Kato N, Ikenoue T, Okamoto M, et al. Reduced C-terminal Src kinase activity is correlated inversely with pp60(c-src) activity in colorectal carcinoma. Cancer 2001;92:61-70. (Pubitemid 32623041)
9. Hermiston ML, Zikherman J, Zhu JW. CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells. Immunol Rev 2009;228:288-311.
10. Wadhawan A, Smith C, Nicholson RI, Barrett-Lee P, Hiscox S. Src-mediated regulation of homotypic cell adhesion: implications for cancer progression and opportunities for therapeutic intervention. Cancer Treat Rev 2011;37:234-41.
11. Gill S, Sinicrope FA. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure? Semin Oncol 2005;32:24-34. (Pubitemid 40250123)
12. American CS. Cancer facts & figures 2010. Atlanta, GA: American Cancer Society; 2010.
13. Bobe G, Sansbury LB, Albert PS, Cross AJ, Kahle L, Ashby J, et al. Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev 2008;17:1344-53.
14. Kim JE, Lee DE, Lee KW, Son JE, Seo SK, Li J, et al. Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3-K. Cancer Prev Res 2011;4:582-91.
15. Young MR, Ileva LV, Bernardo M, Riffle LA, Jones YL, Kim YS, et al. Monitoring of tumor promotion and progression in a mouse model of inflammation-induced colon cancer with magnetic resonance colonography. Neoplasia 2009;11:237-46.
16. Mitsunaga M, Kosaka N, Choyke PL, Young MR, Dextras CR, Saud SM, et al. Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe. Gut 2013;62:1179-86.
17. Bobe G, Barrett KG, Mentor-Marcel RA, Saffiotti U, Young MR, Colburn NH, et al. Dietary cooked navy beans and their fractions attenuate colon carcinogenesis in azoxymethane-induced ob/ob mice. Nutr Cancer 2008;60:373-81. (Pubitemid 351601375)
18. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-51. (Pubitemid 23342492)
19. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003;94:965-73. (Pubitemid 37508979)
20. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998;80(Suppl 1):S147-71.
21. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007;449:1003-7. (Pubitemid 350014593)
22. Irby RB, Yeatman TJ. Role of Src expression and activation in human cancer. Oncogene 2000;19:5636-42.
23. Karni R, Gus Y, Dor Y, Meyuhas O, Levitzki A. Active Src elevates the expression of beta-catenin by enhancement of cap-dependent translation. Mol Cell Biol 2005;25:5031-9. (Pubitemid 40781103)
24. Penuel E, Martin GS. Transformation by v-Src: Ras-MAPK and PI3KmTOR mediate parallel pathways. Mol Biol Cell 1999;10:1693-703. (Pubitemid 29272625)
25. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012;149:1192-205.
26. Kim YS, Milner JA. Dietary modulation of colon cancer risk. J Nutr 2007;137:2576S-9S. (Pubitemid 350058739)
27. Salcedo R, Worschech A, Cardone M, Jones Y, Gyulai Z, Dai RM, et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med 2010;207:1625-36.
28. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997;13:513-609. (Pubitemid 28034534)
29. Talamonti MS, Roh MS, Curley SA, Gallick GE. Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J Clin Invest 1993;91:53-60. (Pubitemid 23037252)
30. Nada S, Okada M, MacAuley A, Cooper JA, Nakagawa H. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature 1991;351:69-72. (Pubitemid 21896537)
31. Okada M. Regulation of the SRC family kinases by Csk. Int J Biol Sci 2012;8:1385-97.
32. Okada M, Nada S, Yamanashi Y, Yamamoto T, Nakagawa H. CSK: a protein-tyrosine kinase involved in regulation of src family kinases. J Biol Chem 1991;266:24249-52. (Pubitemid 21908933)
33. Sabe H, Knudsen B, Okada M, Nada S, Nakagawa H, Hanafusa H. Molecular cloning and expression of chicken C-terminal Src kinase: lack of stable association with c-Src protein. Proc Natl Acad Sci U S A 1992;89:2190-4.
34. Rengifo-Cam W, Konishi A, Morishita N, Matsuoka H, Yamori T, Nada S, et al. Csk defines the ability of integrin-mediated cell adhesion and migration in human colon cancer cells: implication for a potential role in cancer metastasis. Oncogene 2004;23:289-97. (Pubitemid 38142263)
35. Oneyama C, Hikita T, Enya K, Dobenecker MW, Saito K, Nada S, et al. The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src. Mol Cell 2008;30:426-36. (Pubitemid 351672379)
36. Liang F, Luo Y, Dong Y, Walls CD, Liang J, Jiang HY, et al. Translational control of C-terminal Src kinase (Csk) expression by PRL3 phosphatase. J Biol Chem 2008;283:10339-46.
37. Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 2001;90:157-77. (Pubitemid 32913477)
38. Chen H, Yao K, Nadas J, Bode AM, Malakhova M, Oi N, et al. Prediction of molecular targets of cancer preventing flavonoid compounds using computational methods. PLoS ONE 2012;7:e38261.
39. Lee KM, Lee KW, Jung SK, Lee EJ, Heo YS, Bode AM, et al. Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity. Biochem Pharmacol 2010;80:2042-9.
40. Jung SK, Lee KW, Byun S, Kang NJ, Lim SH, Heo YS, et al. Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Res 2008;68:6021-9.